Page 31 - NATIONAL INSTITUTES OF HEALTH (NIH) GUIDELINES FOR CONDUCTING RESEARCH IN MINISTRY OF HEALTH (MOH) INSTITUTIONS & FACILITIES 3RD EDITION 2021
P. 31

For further questions and inquiries, investigator may contact the NRDHM Secretariat at:

                                     Herbal Medicine Research Centre (HMRC),
                                          Institute for Medical Research,
                                           National Institutes of Health,
                                          No.1, Jalan Setia Murni U13/52,
                                          Seksyen U13, Setia Alam, 40170,
                                               Shah Alam, Selangor
                                          Phone: +603 -3362 8888 ext 7958
                                           Email: jkkph_sec@moh.gov.my


            7.3.   Research  involving  Modern Biotechnology and Living Modified Organisms (LMOs):
                  Institutional Biosafety & Biosecurity Committee (IBBC) or Institutional Biosafety
                  Committee (IBC)


                  Research involving Modern Biotechnology and the use of LMOs requires an approval from
                  the Department of Biosafety, Ministry of Environment and Water prior to the commencement
                  of the research [3]. The application can be submitted through the IBBC/IBC of respective
                  facility and institution (if available). For NIH investigators and any collaborative research with
                  NIH, the submission should be sent to IBBC - IMR while for other MOH facility and institution,
                  submission is to be sent to the respective IBBC/IBC (if available).

                  IBBC and IBC is a committee established to advise investigators who are dealing with research
                  activities involving Modern Biotechnology and LMOs. Submission can be made concurrently to
                  IBBC/IBC during the research registration in NMRR.  Research involving Modern Biotechnology
                  needs to submit Research Proposal Declaration Form (Appendix 7 – For NIH investigator)*
                  and Agree to Abide Form (Appendix 8 – For NIH investigator)*.

                  *Other IBBC/IBC might require different type of form to be submitted. Therefore, it is advisable
                  to refer to respective IBBC/IBC for the requirement of the submission.


                  The IBBC/IBC will review all submitted documents to determine research requirement status.
                  BSO and IBBC/IBC secretariat will then advise on either one of the following [16]:

                  a.    If modern biotechnology is NOT USED, no further action is needed.

                  b.    If modern biotechnology is USED, PI can either apply for;
                        -   Exemption Activity or
                        -   Notification for Contained Used Activity or
                        -   Release Activity
                  In addition to that, investigator involves with LMOs need to submit E Form (Notification for
                  Contained Use and Import for Contained Use Activities Involving LMO for Biosafety Levels 1,
                  2, 3 and 4) and Annex 2 (IBC Assessment of Project Proposal Involving Modern Biotechnology
                  Activities) [17]. Both forms can be downloaded from the Department of Biosafety website.
                  (Diagram 5: Modern Biotechnology Research Notifications & Approval Flowcharts)











                                                  NIH Guidelines for Conducting Research in MOH, 2021  15
   26   27   28   29   30   31   32   33   34   35   36